Aclaris Therapeutics, Inc.

Nasdaq:ACRS

Pharmaceutical Preparations·WAYNE, PA

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	2/26/26	→
10-Q	Q3 2025	9/30/25	11/6/25	→
10-Q	Q2 2025	6/30/25	8/7/25	→
10-Q	Q1 2025	3/31/25	5/8/25	→
10-K	FY 2024	12/31/24	2/27/25	→
10-Q	Q3 2024	9/30/24	11/6/24	→
↓

Earnings Releases (8-K)

26 shown

Filed	Period
2/26/26	Q1 FY2026	→
11/6/25	Q4 FY2025	→
8/7/25	Q3 FY2025	→
5/8/25	Q2 FY2025	→
2/27/25	Q1 FY2025	→
11/6/24	Q4 FY2024	→
↓

News (8-K)

54 shown

Filed	Type	Description
3/10/26	Reg FD	Regulation FD Disclosure	→
1/12/26	Reg FD	Regulation FD Disclosure	→
1/6/26	Reg FD	Regulation FD Disclosure	→
10/14/25	Reg FD	Regulation FD Disclosure	→
7/29/25	Reg FD	Regulation FD Disclosure	→
6/30/25	Reg FD	Regulation FD Disclosure	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
6/5/25	S-8	S-8	→
4/24/25	ARS	ARS	→
2/27/25	S-3	S-3	→
12/31/24	424B3	424B3	→
12/19/24	S-3	S-3	→
11/27/24	S-8	S-8	→
↓

Filing History(839 filings)

TypeDateAccessionPeriodSize

8-K

Mar 10, 2026

0001104659-26-0254208-K

Mar 9, 2026

140.5 KB

Mar 3, 2026

0001957554-26-000011

Mar 1, 2026

8.7 KB

10-K

Feb 26, 2026

0001104659-26-02054010-K

Dec 31, 2025

9.5 MB

8-K

Feb 26, 2026

0001104659-26-0200708-K

Feb 26, 2026

361.9 KB

SCHEDULE 13G/A

Feb 9, 2026

0001373604-26-000008

—

6.3 KB

Feb 6, 2026

0001604457-26-000007

Feb 2, 2026

7.9 KB

Feb 6, 2026

0002045027-26-000004

Feb 2, 2026

7.9 KB

Feb 6, 2026

0002076327-26-000002

Feb 2, 2026

8.0 KB

Feb 6, 2026

0002065269-26-000002

Feb 2, 2026

7.9 KB

Feb 6, 2026

0001781549-26-000013

Feb 2, 2026

7.9 KB

Feb 6, 2026

0001957554-26-000009

Feb 2, 2026

7.9 KB

Feb 5, 2026

0001781549-26-000011

Feb 3, 2026

8.7 KB

Feb 5, 2026

0001604457-26-000005

Feb 3, 2026

8.7 KB

Feb 5, 2026

0002045027-26-000002

Feb 3, 2026

7.0 KB

Feb 5, 2026

0001957554-26-000007

Feb 3, 2026

8.7 KB

4/A

Feb 5, 2026

0001781549-26-000009

Feb 1, 2026

16.6 KB

Feb 3, 2026

0001957554-26-000005

Feb 1, 2026

8.7 KB

Feb 3, 2026

0001781549-26-000007

Feb 1, 2026

5.2 KB

4/A

Feb 3, 2026

0001781549-26-000005

Feb 1, 2025

5.3 KB

SCHEDULE 13G/A

Jan 21, 2026

0002012383-26-000630

—

10.6 KB

8-K

Jan 12, 2026

0001104659-26-0026948-K

Jan 12, 2026

12.2 MB

SCHEDULE 13G/A

Jan 9, 2026

0000929638-26-000098

—

13.7 KB

8-K

Jan 6, 2026

0001104659-26-0010768-K

Jan 6, 2026

5.0 MB

Jan 5, 2026

0001604457-26-000003

Jan 2, 2026

8.7 KB

Jan 5, 2026

0001781549-26-000003

Dec 31, 2025

13.8 KB

25 filings shown

Filed	Form	Description
4/24/25	DEFA14A	DEFA14A	→
4/24/25	DEF 14A	DEF 14A	→
4/14/25	PRE 14A	PRE 14A	→
4/25/24	DEFA14A	DEFA14A	→
4/25/24	DEF 14A	DEF 14A	→
4/20/23	DEFA14A	DEFA14A	→
↓

Aclaris Therapeutics, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(839 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
3/3/26	4	4	→
2/6/26	4	4	→
2/6/26	4	4	→
2/6/26	4	4	→
2/6/26	4	4	→
2/6/26	4	4	→
↓

Filed	Form	Description
2/9/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
1/21/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
1/9/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
11/13/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
7/29/25	SCHEDULE 13G	SCHEDULE 13G	→
7/24/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
↓